SEPRACOR INC. 0% CONVERTIBLE SENIOR SUBORDINATED NOTES DUE 2024 PURCHASE AGREEMENTPurchase Agreement • September 22nd, 2004 • Sepracor Inc /De/ • Pharmaceutical preparations • New York
Contract Type FiledSeptember 22nd, 2004 Company Industry JurisdictionSepracor Inc., a Delaware corporation (the “Company”), proposes to issue and sell to Morgan Stanley & Co. Incorporated (the “Initial Purchaser”) $500,000,000 aggregate principal amount of its 0% Convertible Senior Subordinated Notes Due 2024 (the “Firm Securities”) to be issued pursuant to the provisions of an Indenture dated as of September 22, 2004 (the “Indenture”) between the Company and JPMorgan Chase Bank, as Trustee (the “Trustee”). The Company also proposes to issue and sell to the Initial Purchaser not more than an additional $100,000,000 aggregate principal amount of its 0% Convertible Senior Subordinated Notes Due 2024 (the “Additional Securities”) if and to the extent that the Initial Purchaser shall have determined to exercise the right to purchase such 0% Convertible Senior Subordinated Notes Due 2024 granted to the Initial Purchaser in Section 2 hereof. The Firm Securities and the Additional Securities are hereinafter collectively referred to as the “Securities”. The Sec
ATLANTIC COAST AIRLINES HOLDINGS, INC. 6% CONVERTIBLE NOTES DUE 2034 PURCHASE AGREEMENTPurchase Agreement • May 10th, 2004 • Atlantic Coast Airlines Holdings Inc • Air transportation, scheduled • New York
Contract Type FiledMay 10th, 2004 Company Industry JurisdictionAtlantic Coast Airlines Holdings, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to Morgan Stanley & Co. Incorporated (the “Initial Purchaser”) $125,000,000 principal amount of its 6% Convertible Notes due 2034 (the “Firm Securities”) to be issued pursuant to the provisions of an Indenture dated as of February 25, 2004 (the “Indenture”) between the Company and U.S. Bank National Association, as Trustee (the “Trustee”). The Company also proposes to issue and sell to the Initial Purchaser not more than an additional $25,000,000 principal amount of its 6% Convertible Notes due 2034 (the “Additional Securities”) if and to the extent that the Initial Purchaser shall have determined to exercise the right to purchase such 6% Convertible Notes due 2034 granted to the Initial Purchaser in Section 2 hereof. The Firm Securities and the Additional Securities are hereinafter collectively referred to as the “Securities”. The Securities will be convertible into shares of com
DURECT CORPORATION PURCHASE AGREEMENTPurchase Agreement • August 8th, 2003 • Durect Corp • Pharmaceutical preparations • New York
Contract Type FiledAugust 8th, 2003 Company Industry JurisdictionDURECT Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to Morgan Stanley & Co. Incorporated (the “Initial Purchaser”) $50,000,000 principal amount of its 6.25% Convertible Notes due 2008 (the “Firm Securities”) to be issued pursuant to the provisions of an Indenture dated as of June 18, 2003 (the “Indenture”) between the Company and The Bank of New York, as Trustee (the “Trustee”). The Company also proposes to issue and sell to the Initial Purchaser not more than an additional $10,000,000 principal amount of its 6.25% Convertible Notes due 2008 (the “Additional Securities”) if and to the extent that the Initial Purchaser shall have determined to exercise the right to purchase such 6.25% Convertible Notes due 2008 granted to the Initial Purchaser in Section 2 hereof. The Firm Securities and the Additional Securities are hereinafter collectively referred to as the “Securities”. The Securities will be convertible into shares of common stock, par value $0.00